Chubb Limited

NYSE:CB Stock Report

Market Cap: US$117.0b

Chubb Valuation

Is CB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CB ($290.33) is trading below our estimate of fair value ($585.92)

Significantly Below Fair Value: CB is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CB?

Other financial metrics that can be useful for relative valuation.

CB key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.6x
Enterprise Value/EBITDA12.8x
PEG Ratio-181.2x

Price to Earnings Ratio vs Peers

How does CB's PE Ratio compare to its peers?

The above table shows the PE ratio for CB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average15.4x
PGR Progressive
21.9x1.8%US$150.2b
TRV Travelers Companies
14.7x9.0%US$54.2b
ALL Allstate
17.2x12.6%US$50.6b
ACGL Arch Capital Group
7.8x-14.5%US$42.5b
CB Chubb
12.1x-0.07%US$117.0b

Price-To-Earnings vs Peers: CB is good value based on its Price-To-Earnings Ratio (12.1x) compared to the peer average (15.4x).

Price to Earnings Ratio vs Industry

How does CB's PE Ratio compare vs other companies in the US Insurance Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a9.1%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a9.1%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: CB is good value based on its Price-To-Earnings Ratio (12.1x) compared to the US Insurance industry average (14.1x).

Price to Earnings Ratio vs Fair Ratio

What is CB's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CB PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio12.1x
Fair PE Ratio15.2x

Price-To-Earnings vs Fair Ratio: CB is good value based on its Price-To-Earnings Ratio (12.1x) compared to the estimated Fair Price-To-Earnings Ratio (15.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CB forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$290.33
US$282.96
-2.5%
8.5%US$349.00US$236.00n/a22
Sep ’25US$284.18
US$277.86
-2.2%
6.4%US$305.00US$236.00n/a21
Aug ’25US$271.95
US$276.43
+1.6%
6.7%US$305.00US$236.00n/a21
Jul ’25US$254.82
US$270.73
+6.2%
5.5%US$305.00US$236.00n/a22
Jun ’25US$270.82
US$269.50
-0.5%
5.0%US$294.00US$236.00n/a22
May ’25US$249.93
US$266.65
+6.7%
6.3%US$297.00US$226.00n/a23
Apr ’25US$257.40
US$261.17
+1.5%
7.2%US$285.00US$226.00n/a23
Mar ’25US$250.62
US$259.13
+3.4%
7.3%US$285.00US$226.00n/a23
Feb ’25US$244.95
US$253.74
+3.6%
7.6%US$285.00US$220.00n/a23
Jan ’25US$226.00
US$243.68
+7.8%
7.4%US$275.00US$203.00n/a22
Dec ’24US$228.66
US$244.68
+7.0%
7.7%US$277.00US$203.00n/a22
Nov ’24US$220.31
US$244.19
+10.8%
7.6%US$277.00US$203.00n/a21
Oct ’24US$208.18
US$238.55
+14.6%
8.6%US$270.00US$192.00n/a20
Sep ’24US$203.29
US$238.55
+17.3%
8.6%US$270.00US$192.00US$284.1820
Aug ’24US$203.22
US$238.30
+17.3%
8.5%US$270.00US$192.00US$271.9520
Jul ’24US$192.56
US$237.13
+23.1%
8.9%US$270.00US$192.00US$254.8220
Jun ’24US$187.70
US$239.50
+27.6%
7.9%US$270.00US$193.00US$270.8219
May ’24US$202.14
US$241.40
+19.4%
7.7%US$270.00US$193.00US$249.9320
Apr ’24US$194.18
US$242.80
+25.0%
8.4%US$270.00US$185.00US$257.4020
Mar ’24US$209.50
US$243.70
+16.3%
7.3%US$270.00US$205.00US$250.6220
Feb ’24US$213.44
US$245.05
+14.8%
7.2%US$270.00US$205.00US$244.9520
Jan ’24US$220.60
US$235.89
+6.9%
9.4%US$270.00US$175.00US$226.0018
Dec ’23US$218.32
US$232.68
+6.6%
8.9%US$270.00US$175.00US$228.6619
Nov ’23US$213.48
US$231.30
+8.3%
9.2%US$270.00US$175.00US$220.3120
Oct ’23US$181.88
US$229.25
+26.0%
9.2%US$260.00US$165.00US$208.1820
Sep ’23US$192.14
US$228.75
+19.1%
9.5%US$260.00US$165.00US$203.2920

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y